Valuation (100%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.95 | N/A |
| PEG Ratio (TTM) | 0.07 | N/A |
| P/S Ratio (TTM) | 0.00 | N/A |
| P/B Ratio (TTM) | 0.88 | N/A |
| P/FCF Ratio (TTM) | 0.00 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.87 | N/A |
| Price to 5YR AVG FCF Ratio | 0.01 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.13% | N/A |
| ROE (TTM) | 13.39% | N/A |
| Net Profit Margin (TTM) | 25.90% | N/A |
| ROIC 5YR AVG | 7.31% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 90.69% | 44.20% | 49.55% |
| Revenue | 1.55% | 17.70% | 11.78% |
| Net Income | 90.06% | 65.21% | 61.47% |
| Cash Flow | 11.06% | 27.26% | 20.66% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.68 | N/A |
| Quick Ratio (TTM) | 0.68 | N/A |
| D/E Ratio (TTM) | 0.52 | N/A |
| Interest Coverage (TTM) | 7.09 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 0.91 | N/A |
| LTL to 5YR AVG FCF | 4.33 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.95% | N/A |